Abstract
A capillary zone electrophoretic (CZE) method has been developed for the determination of zoledronate and its related impurities (phosphyte and phosphate). Successful separation of the drug from the impurities was achieved using 7.5 mM of phthalic acid adjusted to pH 3.50 with TRIS, as background electrolyte with an indirect detection at 205 nm. The optimized method was validated for specificity, precision, linearity and accuracy. The limit of detection was 1.8 µg ml-1 and the limit of quantification was 5.9 µg ml-1 for phosphyte. The limit of detection was 2.8 µg ml-1 and the limit of quantification was 9.3 µg ml-1 for phosphate. The developed CZE method used to determine zoledronate, phosphyte and phosphate as bisphosphonates impurities can be used to evaluate the quality of regular production samples of zoledronate.
Keywords: Capillary zone electrophoresis, bisphosphonates, zoledronate, impurities.
Current Analytical Chemistry
Title:Zoledronate and Related Impurities Analysis by Capillary Zone Electrophoresis
Volume: 10 Issue: 2
Author(s): Gisela S. Alvarez, María L. Foglia, Daniela E. Camporotondi, S. A. Giorgieri, Martín F. Desimone and Luis E. Díaz
Affiliation:
Keywords: Capillary zone electrophoresis, bisphosphonates, zoledronate, impurities.
Abstract: A capillary zone electrophoretic (CZE) method has been developed for the determination of zoledronate and its related impurities (phosphyte and phosphate). Successful separation of the drug from the impurities was achieved using 7.5 mM of phthalic acid adjusted to pH 3.50 with TRIS, as background electrolyte with an indirect detection at 205 nm. The optimized method was validated for specificity, precision, linearity and accuracy. The limit of detection was 1.8 µg ml-1 and the limit of quantification was 5.9 µg ml-1 for phosphyte. The limit of detection was 2.8 µg ml-1 and the limit of quantification was 9.3 µg ml-1 for phosphate. The developed CZE method used to determine zoledronate, phosphyte and phosphate as bisphosphonates impurities can be used to evaluate the quality of regular production samples of zoledronate.
Export Options
About this article
Cite this article as:
Alvarez S. Gisela, Foglia L. María, Camporotondi E. Daniela, Giorgieri A. S., Desimone F. Martín and Díaz E. Luis, Zoledronate and Related Impurities Analysis by Capillary Zone Electrophoresis, Current Analytical Chemistry 2014; 10 (2) . https://dx.doi.org/10.2174/15734110113099990009
DOI https://dx.doi.org/10.2174/15734110113099990009 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Enhancing Topical Analgesic Administration: Review and Prospect for Transdermal and Transbuccal Drug Delivery Systems
Current Pharmaceutical Design Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer's Disease - A Translational Perspective
CNS & Neurological Disorders - Drug Targets An Overview on the Pharmacokinetics of Quantum Dots
Current Drug Metabolism Aptamer-Mediated Cancer Gene Therapy
Current Gene Therapy Meet Our Editor
Current Metabolomics Therapeutic Antibodies and Other Proteins Obtained by Molecular Display Technologies
Recent Patents on Biotechnology Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies
Current Drug Targets Phytochemistry and Pharmacognosy of Naturally Occurring Prenyloxyanthraquinones
Current Drug Targets The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews The Influence of Natural Substrates and Inhibitors on the Nucleotide- Dependent Excision Activity of HIV-1 Reverse Transcriptase in the Infected Cell
Current Pharmaceutical Design Development of Immunopharmacotherapy Against Drugs of Abuse
Current Drug Discovery Technologies The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Current Pharmaceutical Design Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond
Current Medicinal Chemistry 13C Metabolomics: NMR and IROA for Unknown Identification
Current Metabolomics Computer-Aided Drug Design of Bioactive Natural Products
Current Topics in Medicinal Chemistry Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent
Current Topics in Medicinal Chemistry Small Molecules' Multi-Metabolic Pathways Prediction Using Physico- Chemical Features and Multi-Task Learning Method.
Current Bioinformatics Synthesis and Spectral Characteristics of Gold Nanoparticles Labelled with Fluorescein Sodium
Current Nanoscience Synthesis of Novel Substituted 1,3-diarylpropenone Derivatives and their In Vitro Cytotoxic Activity
Letters in Drug Design & Discovery Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery
Current Pharmaceutical Design